Liver fat is related to cardiovascular risk factors and subclinical vascular disease: The Rotterdam Study

European Heart Journal Cardiovascular Imaging

Volumn 17, Issue 12, 2016, Pages 1361-1367

  Wolff, Lennard ^a   Bos, Daniel ^a   Murad, Sarwa Darwish ^a   Franco, Oscar H ^a   Krestin, Gabriel P ^a   Hofman, Albert ^a   Vernooij, Meike W ^a   Van Der Lugt, Aad ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

CT; Epidemiology; Imaging; Liver fat; Steatosis; Vascular disease

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

AGED; ALCOHOL CONSUMPTION; ARTERY CALCIFICATION; ARTICLE; BLOOD VESSEL CALCIFICATION; CARDIOVASCULAR RISK; CAROTID ARTERY DISEASE; CENTRAL OBESITY; CORONARY ARTERY CALCIFICATION; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE MARKER; EPICARDIAL FAT; EXTRACRANIAL CAROTID ARTERY CALCIFICATION; FATTY LIVER; FEMALE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; IMAGE PROCESSING; INTRACRANIAL CAROTID ARTERY CALCIFICATION; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; OBESITY; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEX DIFFERENCE; SMOKING; SUBCLINICAL VASCULAR DISEASE; VASCULAR DISEASE; WAIST CIRCUMFERENCE; ADIPOSE TISSUE; AGE DISTRIBUTION; CARDIOVASCULAR DISEASES; COHORT ANALYSIS; COMORBIDITY; CORONARY ARTERY DISEASE; DIAGNOSTIC IMAGING; INCIDENCE; MIDDLE AGED; ODDS RATIO; PATHOLOGY; PERICARDIUM; PROCEDURES; PROGNOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX RATIO; SURVIVAL RATE; VASCULAR CALCIFICATION;

ADIPOSE TISSUE; AGE DISTRIBUTION; AGED; CARDIOVASCULAR DISEASES; COHORT STUDIES; COMORBIDITY; CORONARY ARTERY DISEASE; FATTY LIVER; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; INCIDENCE; MALE; MIDDLE AGED; MULTIDETECTOR COMPUTED TOMOGRAPHY; ODDS RATIO; PERICARDIUM; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SURVIVAL RATE; VASCULAR CALCIFICATION;

EID: 85013319786     PISSN: 20472404     EISSN: 20472412     Source Type: Journal    
DOI: 10.1093/ehjci/jew174     Document Type: Article

References (38)

1. World Health Organization. The top 10 causes of death. 2012; (16 March 2015). http://www.who.int/gho/mortality_burden_disease/causes_death/top_10/en/.
2. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006;3:e442.
3. Lonardo A, Ballestri S, Marchesini G, Angulo P, Loria P. Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome. Dig Liver Dis 2015;47:181-90.
4. Galassi A, Reynolds K, He J. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med 2006;119:812-9.
5. Hu KC, Wang HY, Liu SC, Liu CC, Hung CL, Bair MJ et al. Nonalcoholic fatty liver disease: updates in noninvasive diagnosis and correlation with cardiovascular disease. World J Gastroenterol 2014;20:7718-29.
6. Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003;37:917-23.
7. Targher G. Non-alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: the plot thickens. Diabet Med 2007;24:1-6.
8. Petta S, Argano C, Colomba D, Camma C, Di Marco V, Cabibi D et al. Epicardial fat, cardiac geometry and cardiac function in patients with non-alcoholic fatty liver disease: association with the severity of liver disease. J Hepatol 2015;62:928-33.
9. Iacobellis G, Barbarini G, Letizia C, Barbaro G. Epicardial fat thickness and nonalcoholic fatty liver disease in obese subjects. Obesity (Silver Spring) 2014;22:332-6.
10. Graner M, Nyman K, Siren R, Pentikainen MO, Lundbom J, Hakkarainen A et al. Ectopic fat depots and left ventricular function in nondiabetic men with nonalcoholic fatty liver disease. Circ Cardiovasc Imaging 2014;8:e001979.
11. Mellinger JL, Pencina KM, Massaro JM, Hoffmann U, Seshadri S, Fox CS et al. Hepatic steatosis and cardiovascular disease outcomes: an analysis of the Framingham heart study. J Hepatol 2015;63:470 - 6.
12. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K et al. The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 2012;55:2005-23.
13. Hofman A, Brusselle GG, Darwish Murad S, van Duijn CM, Franco OH, Goedegebure A et al. The Rotterdam Study: 2016 objectives and design update. Eur J Epidemiol 2015;30:661-708.
14. Odink AE, van der Lugt A, Hofman A, Hunink MG, Breteler MM, Krestin GP et al. Association between calcification in the coronary arteries, aortic arch and carotid arteries: the Rotterdam Study. Atherosclerosis 2007;193:408-13.
15. Kodama Y, Ng CS, Wu TT, Ayers GD, Curley SA, Abdalla EK et al. Comparison of CT methods for determining the fat content of the liver. AJR Am J Roentgenol 2007; 188:1307-12.
16. Shahzad R, Bos D, Metz C, Rossi A, Kirisli H, van der Lugt A et al. Automatic quantification of epicardial fat volume on non-enhanced cardiac CT scans using a multi-atlas segmentation approach. Med Phys 2013;40:091910.
17. La Grutta L, Toia P, Farruggia A, Albano D, Grassedonio E, Palmeri A et al. Quantification of epicardial adipose tissue in coronary calcium score and CT coronary angiography image data sets: comparison of attenuation values, thickness and volumes. Br J Radiol 2016;89:20150773.
18. Spearman JV, Meinel FG, Schoepf UJ, Apfaltrer P, Silverman JR, Krazinski AW et al. Automated quantification of epicardial adipose tissue using CT angiography: evaluation of a prototype software. Eur Radiol 2014;24:519-26.
19. Bos D, van der Rijk MJ, Geeraedts TE, Hofman A, Krestin GP, Witteman JC et al. Intracranial carotid artery atherosclerosis: prevalence and risk factors in the general population. Stroke 2012;43:1878 - 84.
20. Hofman A, Darwish Murad S, van Duijn CM, Franco OH, Goedegebure A, Ikram MA et al. The Rotterdam Study: 2014 objectives and design update. Eur J Epidemiol 2013;28:889-926.
21. Odink AE, van der Lugt A, Hofman A, Hunink MG, Breteler MM, Krestin GP et al. Risk factors for coronary, aortic arch and carotid calcification: the Rotterdam Study. J Hum Hypertens 2010;24:86-92.
22. World Health Organization. Waist circumference and waist-hip ratio: report of a WHO expert consultation, 2008. http://www.who.int/nutrition/publications/obesity/WHO_report_waistcircumference_and_waisthip_ratio/en/.
23. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M et al. 2013 ESH/ ESC practice guidelines for the management of arterial hypertension. Blood Press 2014;23:3-16.
24. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
25. Velleman PF, Hoaglin DC. Re-expression and the ladder of powers. In: Applications, Basics, and Computing of Exploratory Data Analysis. Boston: Duxbury Press; 1981. p48.
26. Park SH, Kim PN, Kim KW, Lee SW, Yoon SE, Park SW et al. Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment. Radiology 2006;239:105 - 12.
27. Lieber CS. Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. Alcohol 2004;34:9-19.
28. Alkhouri N, Tamimi TA, Yerian L, Lopez R, Zein NN, Feldstein AE. The inflamed liver and atherosclerosis: a link between histologic severity of nonalcoholic fatty liver disease and increased cardiovascular risk. Dig Dis Sci 2010;55:2644-50.
29. Koehler EM, Schouten JN, Hansen BE, van Rooij FJ, Hofman A, Stricker BH et al. Prevalence and risk factors of non-alcoholic fatty liver disease in the elderly: results from the Rotterdam Study. J Hepatol 2012;57:1305-11.
30. Janssen I, Heymsfield SB, Allison DB, Kotler DP, Ross R. Body mass index and waist circumference independently contribute to the prediction of nonabdominal, abdominal subcutaneous, and visceral fat. Am J Clin Nutr 2002;75:683-8.
31. Janssen I, Katzmarzyk PT, Ross R. Waist circumference and not body mass index explains obesity-related health risk. Am J Clin Nutr 2004;79:379-84.
32. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004;40:1387-95.
33. Clark JM, Brancati FL, Diehl AM. The prevalence and etiology of elevated amino-transferase levels in the United States. Am J Gastroenterol 2003;98:960-7.
34. Kotronen A, Yki-Jarvinen H. Fatty liver: a novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol 2008;28:27-38.
35. Al Rifai M, Silverman MG, Nasir K, Budoff MJ, Blankstein R, Szklo M et al. The association of nonalcoholic fatty liver disease, obesity, and metabolic syndrome, with systemic inflammation and subclinical atherosclerosis: the multi-ethnic study of atherosclerosis (MESA). Atherosclerosis 2015;239:629 - 33.
36. Zeb I, Li D, Nasir K, Katz R, Larijani VN, Budoff MJ. Computed tomography scans in the evaluation of fatty liver disease in a population based study: the multi-ethnic study of atherosclerosis. Acad Radiol 2012;19:811-8.
37. Sangiorgi G, Rumberger JA, Severson A, Edwards WD, Gregoire J, Fitzpatrick LA et al. Arterial calcification and not lumen stenosis is highly correlated with atherosclerotic plaque burden in humans: a histologic study of 723 coronary artery segments using nondecalcifying methodology. J Am Coll Cardiol 1998;31:126-33.
38. Rumberger JA, Simons DB, Fitzpatrick LA, Sheedy PF, Schwartz RS. Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study. Circulation 1995;92: 2157-62.